A trial by AIIMS shows digoxin may reduce worsening heart failure in rheumatic heart disease patients, offering a low-cost ...
I’ve spent decades telling other people’s stories on television. This time, the story became my own.
A study of a few patients, to be presented this week, showed promise for a type of therapy that has already cured some blood ...
SCI Corporation ("CEL-SCI" or the "Company") (NYSE American: CVM), a clinical stage cancer immunotherapy company, today ...
New Phase’s technology destroys cancer cells with nanoparticles and electromagnetic hyperthermia in patients with late-stage ...
A treatment that targets dysfunctional photoreceptors regardless of the underlying genetic mutation leads to improved ...
Multikine sales in Saudi Arabia upon receipt of Breakthrough Medicine Designation Amarox to act as the local regulatory representative and lead all communications with the Saudi Food and Drug ...
The opening of Aivee Clinic's newest flagship in the south and the accolades received at the Rejuran Awards 2026 show Aivee ...
Hims & Hers Health, Inc. remains a Buy, with a solid bottom forming despite recent margin and revenue challenges. Read more ...
FDA drug approvals are reshaping biotech stocks—track key decisions, FDA leadership turmoil, and volatility. Click for a look ...
The Chosun Ilbo on MSN
Korean drug industry sees approval surge with two new treatments
Domestic new drugs, which were released at a rate of about one or two per year, have received approval for two new drugs by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results